Filing Details

Accession Number:
0000950156-13-000021
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-15 10:52:05
Reporting Period:
2013-01-02
Filing Date:
2013-03-15
Accepted Time:
2013-03-15 10:52:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
352998 Igi Laboratories Inc IG Biological Products, (No Disgnostic Substances) (2836) 010355758
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184312 C James Gale Carnegie Hall Tower
152 West 57Th St. 19Th Fl.
New York NY 10019
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-13 10,000 $1.33 14,624 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Acquisiton 2013-01-02 15,000 $0.00 15,000 $1.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2014-01-02 2023-01-02 No 4 A Direct
Footnotes
  1. These securities were granted as part of the Issuer's annual equity compensation to its non-employee directors under the Issuer's 1999 Director Stock Option Plan.